Cooley Advises ERYTECH on €25.4 Million Private Placement

Boston – December 9, 2015 – Cooley advised ERYTECH Pharma on a private placement of its ordinary shares to qualified investors in the United States and Europe. Gross proceeds to ERYTECH from the private placement were €25.4 million.

ERYTECH, based in Lyon, France with US headquarters in Boston, is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS platform, which uses a novel technology to encapsulate therapeutic drug substances inside red blood cells, ERYTECH has developed a pipeline of product candidates targeting markets with high unmet medical needs. ERYTECH's ordinary shares are listed on Euronext Paris.

The Cooley team advising ERYTECH was led by partners Marc Recht and Div Gupta and included special counsel Brian Leaf and associates David Bartholomew, Courtney Thorne, Katie Kazem and Katelyn Kimber. Critical support for the private placement was provided by tax associate Stephanie Gentile and corporate partner Francis Wheeler.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.